- Home
- DUOL vs ASND Comparison
DUOL vs ASND Comparison
Compare DUOL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DUOL | ASND |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 12.2B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DUOL | ASND |
|---|---|---|
| Price | $186.56 | $200.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $316.79 | $256.40 |
| AVG Volume (30 Days) | ★ 1.6M | 794.8K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 338.81 | N/A |
| EPS | ★ 8.04 | N/A |
| Revenue | ★ $964,271,000.00 | $758,592,045.00 |
| Revenue This Year | $40.50 | $99.74 |
| Revenue Next Year | $22.65 | $79.40 |
| P/E Ratio | $23.14 | ★ N/A |
| Revenue Growth | 39.86 | ★ 97.46 |
| 52 Week Low | $166.27 | $118.03 |
| 52 Week High | $544.93 | $229.94 |
Technical Indicators
Market Signals| Indicator | DUOL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 45.49 |
| Support Level | $179.08 | $192.28 |
| Resistance Level | $193.64 | $213.22 |
| Average True Range (ATR) | 9.68 | 10.39 |
| MACD | 2.34 | -0.84 |
| Stochastic Oscillator | 21.80 | 22.68 |
Price Performance
Historical ComparisonAbout DUOL Duolingo Inc.
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.